Medical Morphine Market Research Report – Forecast to 2027

Medical Morphine Market Information: By Route of Administration (Oral, Injectables) Application (Arthritis, Cancer, Kidney Stones,) Distribution Channel (Hospital Pharmacy, Online Pharmacy), and End-User (Hospitals & Clinics )– Forecast Till 2027

ID: MRFR/Pharma/4626-HCR | February 2021 | Region: Global | 100 pages

Medical Morphine Market Scenario:

The medical morphine market is expected to register a CAGR of 7.5% during the forecast period of 2018–2023. The medical morphine market is majorly driven by the increasing prescription of painkillers for different illnesses such as arthritis, cardiovascular disorders, and cancer, the growing older population leading to the rising patient population, and growing penetration by market players. For instance, according to the American Heart Association, in 2014, one in every three deaths in the U.S. was due to cardiovascular disorders. Similarly, cardiovascular disorders had claimed over 801,000 lives in 2014 in the U.S. Additionally, the increasing use of painkillers to relieve pain in postoperative surgeries is likely to drive the growth of the morphine market globally. However, addiction to morphine leading to drug abuse is likely to hamper the growth of the market. Likely the limited regulatory scenario is also expected to turn as a challenge for the market.

Market Segmentation

The morphine market has been segmented by route of administration, application, distribution channel, end-user, and region. Further, the market by route of administration is segmented into oral and injectables. Based on application, the market is segmented into arthritis, cancer, myocardial infarction, kidney stones, diarrhea, and others. With reference to distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others. On account of end-user, the market is segmented into hospitals and clinics, home care, and ambulatory surgical centers. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.

Regional Market Summary

Global Medical Morphine Market Share (%), by Region, 2017

Medical Morphine Market Share

Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, annual report, white paper, company presentation and market research future analysis

Americas held the largest share of the market in 2017. The increasing prevalence of arthritis and other inflammatory disorders and rising more elderly population are likely to enhance the growth of the market in the American region. Additionally, factors such as prescription of painkillers, increasing government initiatives, and funding for research and development in advanced medical treatment options are likely to enhance the growth of the medical morphine market in the American region. For instance, according to the American Heart Association, in 2014, around 31% of the deaths in the U.S. were due to cardiovascular disorders. Additionally, according to CDC, around 54.4 million U.S. adults were affected by arthritis in 2015. This growth rate of cardiovascular disorders and arthritis is expected to have a direct effect on medical morphine as it helps to relieve joint pain and postsurgical pain.

Europe is the second-largest market and is expected to hold a healthy share in the global medical morphine market during the forecast period, 2018–2023. The European market is expected to grow at a sturdy growth rate during the forecast period owing to the lucrative growth of the healthcare sector coupled with the increasing prevalence of arthritis. Furthermore, increasing inflammatory disorders, along with the rising elder population leading to increasing patient population are also supporting the growth of the market.

Asia Pacific is expected to be the fastest growing market during the forecast period of 2018–2023. Factors such as the increasing prevalence of chronic diseases such as cardiovascular disorders are the major drivers for the market growth. China is expected to be the fastest growing country due to increasing population, eventually rising patient population and the availability of new treatment methods. Moreover, rising healthcare expenditure in the region is driving the growth of the medical morphine market in the Asia Pacific region.

The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market owing to the development of the healthcare industry and rising availability of specialty care centers.

Research Methodology:

Medical Morphine Market Method

Source: World Health Organization, Centers for Disease Control and Prevention, American Heart Association, National Institute of Health, American College of Cardiology, European Heart Network, expert interview, annual report, white paper, company presentation and market research future analysis

Market Segmentation & Key players

Medical Morphine Market, by Route of Administration

Oral

Injectables

Others

Medical Morphine Market, by Application

Arthritis

Cancer

Myocardial infarction

Kidney stones

Diarrhea

Others

Medical Morphine Market, by Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

Medical Morphine Market, by End-User

Hospitals & Clinics

Ambulatory Surgical Centers

Homecare

Others

Medical Morphine Market, by Region

North America

U.S.

Canada

South America

Europe

Western Europe

Germany

France

Italy

Spain

Rest of Western Europe

Eastern Europe

Asia Pacific

Japan

China

India

Australia

Republic of Korea

Rest of Asia Pacific

Middle East and Africa

United Arab Emirates

Saudi Arabia

Oman

Kuwait

Qatar

Rest of the Middle East & Africa

Market Players

Mallinckrodt Pharmaceuticals

Alcaliber S.A

Purdue Pharma L.P.

Pfizer Inc.

Johnson Matthey Fine Chemicals

Sun Pharmaceutical Industries Ltd.

Verve Health Care Ltd.

Taj Pharmaceuticals Limited

NORTHEAST PHARM

MANUS AKTTEVA BIOPHARMA LLP

Intended Audience

Pharmaceutical Manufacturers and Suppliers

Medical Research Laboratories

Research and Development (R&D) Companies

Market Research and Consulting Service Providers

Potential Investors

Report Scope:

Report Attribute/Metric	Details
Market Size	Significant Value
CAGR	2018-2023: 7.5%
Base Year	2019
Forecast Period	2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Route Of Administration, Application, Distribution Channel, End-User, And Region
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Mallinckrodt Pharmaceuticals, Alcaliber S.A, Purdue Pharma L.P., Pfizer Inc., Johnson Matthey Fine Chemicals, Sun Pharmaceutical Industries Ltd., Verve Health Care Ltd., Taj Pharmaceuticals Limited, NORTHEAST PHARM, MANUS AKTTEVA BIOPHARMA LLP
Key Market Opportunities	Increasing government initiativesa Funding for research and development in advanced medical treatment options
Key Market Drivers	Large geriatric populace and prevalence of cardiovascular diseases

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

What is the growth rate of the global medical morphine market?

The global medical morphine market can expand at 7.5% CAGR from 2020 to 2027.

What are the major growth drivers of the global medical morphine market?

The large geriatric populace and prevalence of cardiovascular diseases and others are major drivers of the global medical morphine market.

What is the major restraint of the global medical morphine market?

The global medical morphine market growth is hampered by cases of painkiller medication.

Which region can dominate the global medical morphine market?

The Americas can dominate the global medical morphine market till 2027 due to prevalence of arthritis and cardiovascular disorders.

Who are the major players of the global medical morphine market?

MANUS AKTTEVA BIOPHARMA LLP, Purdue Pharma L.P., Johnson Matthey Fine Chemicals, NORTHEAST PHARM, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Verve Health Care Ltd., Alcaliber S.A, Mallinckrodt Pharmaceuticals, and Taj Pharmaceuticals Limited are major players of the global medical morphine market.

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Medical Morphine Market, by Route of Administration

6.1 Introduction

6.2 Oral

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

6.3 Injectables

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

6.4 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7. Global Medical Morphine Market, by Application

7.1 Introduction

7.2 Arthritis

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.3 Cancer

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.4 Myocardial infarction

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.5 Kidney stones

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.6 Diarrhea

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.7 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

8. Global Medical Morphine Market, by Distribution Channel

8.1 Introduction

8.2 Hospital Pharmacy

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

8.3 Retail Pharmacy

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

8.4 Online Pharmacy

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

8.5 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

•

9. Global Medical Morphine Market, by End-User

9.1 Introduction

9.2 Hospitals & Clinics

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

9.3 Ambulatory Surgical Centers

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

9.4 Homecare

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

9.5 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

10 Global Medical Morphine Market, by Region

10.1 Introduction

10.2 Americas

• Market Estimates & Forecast, by Region, 2020–2027

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027